NIDIA HALL: Open Payments
NPI 1083308951 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 24 payments from 14 companies in 2025. Trend: 2023 $20 · 2024 $1,817 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 3 | $70 |
| 3B Medical, Inc. | 2 | $62 |
| Verona Pharma, Inc. | 3 | $57 |
| Lilly USA, LLC | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Alexion Pharmaceuticals, Inc. | 2 | $35 |
| Insulet Corporation | 1 | $34 |
| BETA BIONICS, INC. | 1 | $28 |
| JAZZ PHARMACEUTICALS INC. | 1 | $26 |
Products named: YUPELRI, LUNA, Ohtuvayre, MOUNJARO, DUPIXENT, STRENSIQ, Omnipod, iLet Bionic Pancreas.
Industry payments across MD — which companies pay providers there.
